Analysen von James Gordon
06.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
02.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
18.01.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
15.01.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
29.12.17 | AstraZeneca overweight | JP Morgan Chase & Co. | |
12.12.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
08.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
07.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
02.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
06.10.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
31.03.16 | Roche overweight | JP Morgan Chase & Co. | |
08.12.15 | MorphoSys overweight | JP Morgan Chase & Co. |